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Brucellosis is a zoonosis caused by microorganisms of 
the genus Brucella. In Europe, the human disease is 
endemic in Portugal, as it is in countries of the Medi- 
terranean basin [l]. Recognition of acute infection is 
easy when the presentation is typical but, even in 
endemic areas, the varied and sometimes non-specific 
manifestations of the disease may be responsible for 
misdiagnosis of some cases. The diagnosis of the infec- 
tion is established with certainty when brucellae are 
isolated from body tissues or fluids, mainly blood [1,2]. 
Brucella spp. are fastidious microorganisms and, tradition- 
ally, blood cultures should be held for 30 days instead 
of the typical 5-7 days before being discarded as 
negative [3] .  Some modern automatic blood culture 
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systems have reduced detection times from weeks to 
days [3-71, but data on their performance are limited. 
The VITAL system (bioMCrieux, Marcy-l’Etoile, 
France) is a new continuously monitoring blood culture 
system based on novel homogeneous fluorescence 
technology. Detection of microbial growth is measured 
by a decrease in fluorescence [8]. To evaluate the 
performance of the VITAL system for the detection of 
Briicella bacteremia in comparison with a traditional 
blood culture method used in our laboratory, a pro- 
spective study was conducted in a Lisbon hospital over 
a 40-month period. 
In Portugal, the numbers of cases of brucellosis in 
humans reported in 1995-97 were 915, 860 and 866 
respectively [9]. Infection occurs due to consumption 
of fresh, unpasteurized milk cheese (a local delicacy) 
from unvaccinated sheep or goats. Hospital de Santa 
Maria is the largest (1300-bed) hospital in Lisbon. From 
July 1995 to October 1998, patients admitted to the 
hospital with a suspected diagnosis of brucellosis on 
the basis of clinical or epidemiologic grounds were 
included in the study. 
Between 5 and 10mL of blood obtained by 
venipuncture from patients was inoculated into VITAL 
AEK (aerobic) bottles and bottles containing 80 mL of 
Tryptose Broth (Difco). In each set of blood cultures, 
equal volumes of blood were inoculated into both the 
VITAL AER and the Tryptose Broth bottles. The 
number of blood culture sets was left to the clinician’s 
discretion, from one to four. In many patients, further 
blood cultures in VITAL. AER bottles were obtained, 
as this was the system used for detection of positive 
aerobic blood cultures in the hospital. 
VITAL AER bottles were placed in the analysis 
module at the laboratory either within 1 h after they 
were inoculated or after a preincubation in temporary 
storage incubators at 35OC. Duration of the incubation 
period in the system was 10 days. Bottles flagged 
positive were visually inspected (checking for hemolysis, 
turbidity or color change of the broth) and subcultured 
onto blood agar and chocolate polyvitex agar at 35°C 
for 48 h. Chocolate polyvitex agar subcultures were 
incubated in 10% COz. All negative bottles were also 
submitted to visual inspection and subcultured onto 
blood agar at 35°C for 48 h. When subcultures were 
negative, they were further incubated at  35°C for 3 
weeks and subcultured weekly onto blood agar plates at 
35OC for 48 h. 
Tryptose Broth bottles were incubated at 35°C for 
4 weeks. Once a week, all bottles were subcultured 
onto tryptose agar slants at 35°C for 48 h. 
The microorganisms cultured were isolated and 
identified by conventional techniques. Bri~ella sp. isolates 
were identified on the basis of colony morphology, 
typical microscopic morphology of small Grani- 
negative coccobacilli, no growth on MacConkey agar 
and agglutination with specific anti-Brucella serum. 
The-chi-square test was used for comparison of 
variables. 
During the 40-month study period, 1090 blood 
culture bottles from 361 patients were processed. One 
set of blood cultures was obtained from 239 patients, 
two from 64, three from 54 and four from four. In 181 
of these patients, further additional VITAL AER blood 
cultures (364 bottles) were studied without concomit- 
ant Tryptose Broth. Bnicella sp. grew from 118 bottles 
(31 different patients). Results of the detection of the 
microorganism by the two culture methods are shown 
in Table 1. 
Considering only the 545 sets of blood cultures, 
the VITAL system detected 18 positive bottles during 
the maximum incubation period permitted by the 
software (10 days). After subculture of all negative 
bottles, another 30 grew Brucella sp. (sensitivity 37.5%). 
The study of the further 364 VITAL AER bottles 
obtained from the same group of patients showed that 
the system detected seven positive bottles and another 
12 grew Bnirella sp. after subculture of all negative 
bottles. 
Considering all bottles from each patient, 13 cases 
were detected by the VITAL system and the Tryptose 
Broth culture, 15 by the Tryptose Broth culture but not 
Table 1 Detection of Brutella sp. in blood cultures by the VITAL system and Tryptose Broth culture 
No 
Cultures positive on day: 
Culture Cultures Positive Patients 
cultures 4 5 6 7 8 9 10” 14 21 28 
Tryptose Broth 545 51 31 ND ND ND 26 ND ND ND 19 6 0 
VITAL AER 545 48 38 2 0 4 9 ’. 1 30 0 0 0 
VITALAERb 364 19 - 0  1 1 1 3 1 12 0 0 0 
”False-negative cultures detected by routine subculture after 10 days of incubation in the system without growth detection. 
hFurther blood cultures obtained from the same group of patients (see text). 
ND - not done. 
3 
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by the VITAL system (although subculture of negative 
bottles grew Brucella sp.), and three only by the 
Tryptose Broth culture. Visual control showed that 
neither positive nor false-negative bottles revealed 
clear signs of microbial growth. A slight or moderate 
turbidity was the most common pattern, and was 
identical to the pattern observed in many true-negative 
bottles. 
Other microorganisms isolated from the blood 
cultures included Staphylococcus aureus (1 8 bottles; five 
patients), Escherichia coli (14; 3),  Streptococcus mitis (6; l), 
Salmonella typhi (3; 2), Streptococcuspneumoniae (2; 1) and 
Streptococcus pyogenes (2; 1). Coagulase-negative staphylo- 
cocci, considered as contaminants, were isolated from 
22 Tryptose Broth bottles and from 13 VITAL AER 
bottles. 
The use of continuous-monitoring blood culture 
systems is now common in the USA, Canada and many 
European countries. They have several advantages over 
the traditional methods, includmg earlier detection of 
microbial growth, decrease in specimen handling and 
the ability to eliminate routine terminal subcultures of 
all bottles [10,11]. Reports of the performance of these 
systems in the detection of Brucella organisms are scarce 
because brucellosis is now eradicated or uncommon in 
these geographic areas [12]. However, as with other 
travel-associated infections, the disease may be con- 
tracted in endemic areas and become symptomatic 
when the patient returns to the country of origin. 
Of the 31 cases of Brucella bacteremia studied, all 
were detected with the Tryptose Broth cultures and 28 
with the VITAL system (P>O.5) but, if all negative 
VITAL AER bottles had not been subcultured, the 
system would have detected a significantly lower 
(P<O.OOl) number of cases. Our results are different 
from those observed by Ruiz et al[5], who did not find 
false-negative cultures with this system in the diagnosis 
of brucellosis. All 16 bottles were flagged positive 
within 10 days, although more slowly than with the 
other two methods under comparison (HCmoline 
performance diphasic mecGum and BACTEC Plus 
Aerobic/F*). Using other automated blood culture 
systems, Yagupsky [13] with BACTEC NR660 
detected 21 of 27 B. melitensis isolates within 7 days, 
and six positive cultures by subculture after 2 or 3 
weeks. With BACTEC 9120, much better results were 
reported by Gedikoglu et a1 [14], who recovered 15 
isolates after 4 days, and by Ruiz et al [5], who detected 
16 Brucella strains in 2.5 to 5 days. One case of early 
detection (2.8 days) was also reported by Solomon and 
Jackson using BACT-ALERT [6]. Recently, Yagupsky 
et al [7] and Bannatyne et al [4], using the BACTEC 
9240, reported the detection of all 28 and 97 Brucella 
isolates within 5 and 9 days respectively. 
If systematic subculture of negative bottles had not 
been done, more than 60% of positive cultures growing 
Brucella sp. would have been missed with the VITAL 
system. With the same system, Avril et al. [15] did not 
report the occurrence of false negatives, and Marchandin 
et al [8] detected 0.05% false-negative bottles, but, as in 
these studies routine terminal subcultures of all negative 
bottles were not done, the real number of false nega- 
tives cannot be determined. Furthermore, Brucella sp. 
organisms were not isolated. Despite the very high 
number of false negatives found in our study, the main 
problem was in the mechanism of microbial detection 
of the instrument rather than in the nutritive quality of 
the broth. In all cases, the microorganisms grew well in 
the bottles, as judged by the confluent growth on the 
subculture plates. A similar problem involving different 
microorganisms (seven yeasts, five staphylococci, one 
Enterococcus faecalis and one Enterobacter sp.) was reported 
by Zaidi et a1 [16], with 14 false-negative VITAL AER 
cultures. 
Final visual inspection did not permit the detection 
of the false negative bottles, because many of them did 
not show clear signs of microbial growth. These obser- 
vations are in contrast with the report of Marchandin et 
al [8], who suggested that rapid visual inspection of the 
bottles before their disposal is sufficient to detect the 
false-negative bottles. However, these authors did not 
carry out systematic subculture of the negative bottles 
and did not report the isolation of any Brucella strain. 
During the 40-month study period, all other blood 
cultures with the VITAL system processed in the 
laboratory were subcultured routinely at the end of the 
incubation time. Overall, 1.1% false negatives were 
detected. These included bacteria and yeasts with the 
following distribution: 29.8% coagulase-negative 
staphylococci, 12.9% Staphylococcus aureus, 10.3% 
Enterobacteriaceae (Eschevichia coli, Klebsiella spp., 
Enterobacter cloacae, Proteus mirabilis and Citrobacter 
diversus), <5% Pseudomonas aeruginosa, Stenotrophomonas 
maltophilia, Brucella sp., Corynebacterium sp., Bacillus sp., 
Streptococcus pyogenes, Streptococcus pneumoniae and CY- 
hemolytic streptococci, 15.2% Candida albicans, 6.7% 
Cryptococcus neoformans, 5.1% Candida tropicalis and 5.7% 
other yeasts (Candida parapsilosis, Candida glabrata, 
Candida lusitanae and Candida kruseg. 
Brucella sp. organisms were isolated from eight 
additional VITAL AER bottles (four patients) which 
did not have Tryptose Broth cultures. Six were not 
detected as positive by the system and two were flagged 
positive on the ninth day. The VITAL system, there- 
fore, detected only 36.0% of all VITAL AER blood 
culture bottles growing Brucella sp. 
On the basis of what was found in our study, in 
countries where brucellosis is endemic or when the 
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clinical diagnosis of the infection is suspected, if the 
negative bottles to maximize detection of the micro- 
organism. This procedure is time-consuming, expen- 
sive and poses a potential threat to the laboratory 
technicians while they are subculturing the bottles. As 
7. Yagupsky P, Peled N, Press J, Abramson 0, Abu-Kashid M. 
VITAL system is used, it is mandatory to subculture all Comparison of BACTEC 9240 Ped Plus medium and Isolator 
1.5 Microbial Tube for detection of Brucella melitemis from blood 
cultures. J Clin Microbiol 1997; 35: 13823.  
8. Marchandin H, Compan B, Simeon de Bouchberg M, Despaux 
E, Perez C. Detection kinetics for positive blood culture bottles 
by using VITAL automated system. J Chn Microbiol 1995; 33: 
the main problem is in the trigger of the sensor rather 2098-101. _ _  
than the growth of the microorganisms in the broth, 
the VITAL system is not presently adequate and needs 
improvement to detect the growth of Brucella spp. 
9. Direcgio Geral da Saude. Doensas de declaraGlo obrigatbria 
1993/1997, Lisboa: Direcg5o doc Servicos de Informagao e 
Anihse, Divisao de Epidemiologia, 1998. 
10. Weinstein MP. Current blood culture methods and systems: 
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All acellular pertussis vaccines include detoxified 
pertussis toxin; some also include filamentous hemag- 
glutinin (FHA), pertactin and/or fimbriae (agglutino- 
gens). Pertussis toxin (PT) is an extracellular toxin of 
Bovdetella pevtussis, while FHA and pertactin are 
immunogenic surface proteins of the organism. Almost 
all patients with pertussis have a serum antibody 
response to PT and FHA, and a majority also to 
pertactin [1,2], and recent data indicate that protection 
against pertussis is related to serum antibodies against 
PT and pertactin [ 3 ] .  PT is specific for B. pertussis, 
while FHA and pertactin are present also in B. 
parapertussis [4,5]. 
It was recently shown that non-encapsulated 
Haemophilus inzuenzae has surface proteins which cross- 
react with FHA of €3. pertussis [6] .  This led to the 
